SUPPLEMENTARY FINANCIAL STATEMENT INFORMATION

12 Months Ended

Dec. 31, 2023

Disclosure of supplementary financial statement information [Abstract]

SUPPLEMENTARY FINANCIAL STATEMENT INFORMATION

NOTE 18 – SUPPLEMENTARY FINANCIAL STATEMENT INFORMATION

a. Other receivables

	December 31,
	2022		2023
	in USD thousands
Advance payments		-		480
Government institutions		687		245
Other		34		105
		721		830

b. Accounts payable and accruals

	December 31,
	2022		2023
	in USD thousands
1) Trade:
Accounts payable:
Overseas		6,061		7,704
In Israel		905		3,165
		6,966		10,869
2) Other:
Payroll and related expenses		931		2,184
Accrued expenses		352		662
Accrual for vacation and recreation pay		377		419
Other		84		88
		1,744		3,353

The carrying amounts of accounts payable and accruals approximate their fair value, as the effect of discounting is not material.

c. Revenues

	Year ended December 31,
	2021		2022		2023
	in USD thousands
License revenues (see Note 16)		-		-		4,610
Product sales, net		-		-		190
		-		-		4,800

d. Cost of revenues

	Year ended December 31,
	2021		2022		2023
	in USD thousands
Cost related to license revenues		-		-		3,230
Amortization of intangible asset in respect of license revenues		-		-		450
Cost of product sales		-		-		12
		-		-		3,692

e. Research and development expenses

	Year ended December 31,
	2021		2022		2023
	in USD thousands
Research and development services		12,088		9,296		4,603
Payroll and related expenses		4,074		4,495		4,452
Lab, occupancy and telephone		882		902		969
Professional fees		595		954		935
Share-based compensation		971		1,198		760
Depreciation and amortization		660		615		583
Other		196		169		217
		19,466		17,629		12,519

f. Sales and marketing expenses

	Year ended December 31,
	2021			2022		2023
	in USD thousands
Payroll and related expenses		308			947		8,868
Medical Affairs		-			1,316		4,824
Marketing		700			1,805		4,091
Office related expenses		-			519		1,923
Market Access		-			1,023		1,606
Business Analytics		-			106		1,005
Travel		25			84		986
Share-based compensation		(59	)		112		751
Professional fees		-			521		745
Depreciation and amortization		-			-		314
Other		29			29		158
		1,003			6,462		25,270

g. General and administrative expenses

	Year ended December 31,
	2021		2022		2023
	in USD thousands
Payroll and related expenses		1,408		1,706		2,117
Professional fees		1,103		1,248		2,028
Insurance		1,064		1,046		939
Share-based compensation		583		895		780
Depreciation		42		39		37
Other		108		132		409
		4,308		5,066		6,310

h. Non-operating income (expenses), net

	Year ended December 31,
	2021			2022			2023
	in USD thousands
Changes in fair value of warrants		(1,936	)		6,425			(11,054	)
Issuance costs		-			(762	)		-
Other		106			7			235
		(1,830	)		5,670			(10,819	)

i. Financial income

	Year ended December 31,
	2021		2022		2023
	in USD thousands
Interest income		277		694		2,007
Exchange differences, net		282		-		61
		559		694		2,068

j. Financial expenses

	Year ended December 31,
	2021		2022		2023
	in USD thousands
Interest expense		984		1,786		2,144
Bank commissions		22		26		25
Exchange differences, net		-		346		-
		1,006		2,158		2,169